Keyphrases
Inflammatory Cytokines
100%
Cutaneous Leishmaniasis
100%
Transforming Growth Factor-β
100%
Chronic Lesions
100%
Interleukin-10
75%
Tumor Necrosis Factor-α
75%
Gene Expression
50%
Interleukin-1β
50%
Interleukin-5 (IL-5)
50%
Interferon-γ
50%
Cytokine Gene Expression
50%
Cellular Immune Response
25%
Inhibitory Effect
25%
Early Lesions
25%
Leishmania
25%
Interleukin-4 (IL-4)
25%
Quantitative PCR
25%
Experimental Animals
25%
Immunopathogenesis
25%
IL-6/IL-10
25%
Disease Progression
25%
IL-3
25%
Interleukin-2
25%
Leishmania Mexicana
25%
IL Interleukin
25%
Macrophage Function
25%
Single Lesion
25%
Animal Control
25%
Localized Cutaneous Leishmaniasis
25%
Interleukin-4 Gene
25%
Immunology and Microbiology
Proinflammatory Cytokine
100%
Cutaneous Leishmaniasis
100%
Gene Expression
100%
Interleukin 10
100%
Transforming Growth Factor Beta
100%
Tumor Necrosis Factor Alpha
75%
Cytokine
50%
Interleukin 4
50%
Interleukin-1
50%
Interferon Gamma
50%
Interleukin 5
50%
Adoptive Immunity
25%
Leishmania
25%
Experimental Animal
25%
Immunopathogenesis
25%
Protozoa
25%
Interleukin 6
25%
Leishmania mexicana
25%
Interleukin 2
25%
Macrophage Function
25%
Reverse Transcription Polymerase Chain Reaction
25%
Pharmacology, Toxicology and Pharmaceutical Science
Skin Leishmaniasis
100%
Cytokine
100%
Interleukin 10
100%
Transforming Growth Factor Beta
100%
Tumor Necrosis Factor
75%
Infection
50%
Gamma Interferon
50%
Interleukin 4
50%
Interleukin 5
50%
Disease
25%
RNA Directed DNA Polymerase
25%
Leishmania
25%
Immunopathogenesis
25%
Protozoon
25%
Interleukin 6
25%
Experimental Animal
25%
Disease Exacerbation
25%
Leishmania mexicana
25%
Interleukin 2
25%
Veterinary Science and Veterinary Medicine
Cancer Growth Factor
100%
Macrophage
25%